Drug General Information |
Drug ID |
D0I9VY
|
Former ID |
DNC011942
|
Drug Name |
CV-4093
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C35H40Cl2N4O6
|
Canonical SMILES |
CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC<br />=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC.Cl.Cl
|
InChI |
1S/C35H38N4O6.2ClH/c1-24-30(34(40)44-3)32(28-15-10-16-29(23-28)39(42)43)31(25(2)36-24)35(41)45-22-21-37-17-19-38(20-18-37)33(26-11-6-4-7-12-26)27-13-8-5-9-14-27;;/h4-16,23,32-33,36H,17-22H2,1-3H3;2*1H
|
InChIKey |
JINNGBXKBDUGQT-UHFFFAOYSA-N
|
PubChem Compound ID |
|
Target and Pathway |
Target(s) |
Voltage-dependent L-type calcium channel alpha-1D subunit |
Target Info |
Inhibitor |
[1]
|
Voltage-dependent L-type calcium channel subunit alpha-1C |
Target Info |
Inhibitor |
[1]
|
KEGG Pathway
|
MAPK signaling pathway
|
Calcium signaling pathway
|
cGMP-PKG signaling pathway
|
cAMP signaling pathway
|
Cardiac muscle contraction
|
Adrenergic signaling in cardiomyocytes
|
Vascular smooth muscle contraction
|
Circadian entrainment
|
Retrograde endocannabinoid signaling
|
Glutamatergic synapse
|
Cholinergic synapse
|
Serotonergic synapse
|
GABAergic synapse
|
Dopaminergic synapse
|
Insulin secretion
|
GnRH signaling pathway
|
Oxytocin signaling pathway
|
Type II diabetes mellitus
|
Carbohydrate digestion and absorption
|
Alzheimer's disease
|
Amphetamine addiction
|
Hypertrophic cardiomyopathy (HCM)
|
Arrhythmogenic right ventricular cardiomyopathy (ARVC)
|
Dilated cardiomyopathyhsa04010:MAPK signaling pathway
|
Long-term potentiation
|
Dilated cardiomyopathy
|
NetPath Pathway
|
IL2 Signaling Pathway
|
PANTHER Pathway
|
Alzheimer disease-amyloid secretase pathway
|
Nicotinic acetylcholine receptor signaling pathway
|
5HT2 type receptor mediated signaling pathway
|
Beta1 adrenergic receptor signaling pathway
|
Beta2 adrenergic receptor signaling pathway
|
Oxytocin receptor mediated signaling pathwayP00003:Alzheimer disease-amyloid secretase pathway
|
Oxytocin receptor mediated signaling pathway
|
Nicotine pharmacodynamics pathway
|
PathWhiz Pathway
|
Muscle/Heart Contraction
|
Reactome
|
Adrenaline,noradrenaline inhibits insulin secretion
|
NCAM1 interactions
|
Regulation of insulin secretionR-HSA-400042:Adrenaline,noradrenaline inhibits insulin secretion
|
Regulation of insulin secretion
|
WikiPathways
|
Calcium Regulation in the Cardiac Cell
|
Arrhythmogenic Right Ventricular Cardiomyopathy
|
Alzheimers Disease
|
NCAM signaling for neurite out-growth
|
Integration of energy metabolismWP536:Calcium Regulation in the Cardiac Cell
|
Integration of energy metabolism
|
Nicotine Activity on Chromaffin Cells
|
References |
REF 1 | J Med Chem. 1989 Oct;32(10):2399-406.Dihydropyrimidines: novel calcium antagonists with potent and long-lasting vasodilative and antihypertensive activity. |